doi:10.1369/jhc.5A6794.2005
Volume 54 (4): 473-477, 2006 Copyright ©The Histochemical Society, Inc. Assessing the Expression of Enterotoxigenic Escherichia colispecific Surface Antigens in Recombinant Strains by Transmission Electron Microscopy and Immunolabeling
Division of Veterinary Anatomy (SL,MHS), Department of Veterinary Bacteriology (SL,JF), University of Berne Veterinary School, Bern, Switzerland, and Berna Biotech Ltd, Bern, Switzerland (DF) Correspondence to: PD Dr. med.vet. Michael H. Stoffel, Division of Veterinary Anatomy, University of Berne, POB 8466, CH-3001, Bern, Switzerland. E-mail: michael.stoffel{at}ita.unibe.ch
Infections with enterotoxigenic Escherichia coli (ETEC) are a major cause of travelers' diarrhea worldwide. Colonization of the small intestine mucosa is dependent on specific colonization factor antigens (CFA) and coli surface (CS) antigens. CFA/1, CS3, and CS6 are the most prevalent fimbrial antigens found in clinical isolates. The goal of our study was to visualize the morphology of CS3 and CS6 fimbriae in wild-type and recombinant E. coli strains by means of transmission electron microscopy in conjunction with negative staining and immunolabeling. Corresponding ETEC genes were cloned into E. coli K12 strain DH10B. Expression of fimbriae was dependent on culture conditions and sample handling. Specific immunolabeling of fimbriae unequivocally demonstrated the presence of all types of surface antigens investigated. Negative staining was effective in revealing CS3 but not CS6. In addition, this technique clearly demonstrated differences in the morphology of genetically and immunologically identical CS3 surface antigens in wild-type and recombinant strains. This paper provides a basis for the assessment of recombinant vaccines. (J Histochem Cytochem 54:473477, 2006)
Key Words: CS3 CS6 fimbriae immunolabeling negative staining vaccine
SUCCESSFUL ADHESION of enterotoxigenic Escherichia coli (ETEC) to the small intestine mucosa is a precondition for the development of diarrhea. This crucial step in pathogenesis is mediated through specific surface structures called pili or fimbriae (Jonson et al. 2005 75% of human ETEC express either the colonization factor CFA/I, CFA/II, or CFA/IV (Kaper et al. 2004The goal of the present study was to establish appropriate methods to demonstrate the expression of surface antigens in recombinant strains of E. coli. A method of negative staining and immunogold labeling of a recombinant acceptor E. coli-K12 strain DH10B expressing either CS3 or CS6 was adopted to monitor the presence and morphology as well as the antigenic potential of fimbriae as compared with selected wild-type strains. The present study clearly demonstrates the value of this approach for the validation of recombinant strains in view of their potential as vaccine candidates.
Investigated wild-type strains and recombinant strains, as well as plasmids used for their transformation, are specified in Table 1 .
Culture Conditions and Collection of Bacteria in Suspension After testing various protocols, bacteria were grown in CFA medium (Evans et al. 1979
Negative Staining
Immunolabeling For immunogold labeling, grids were floated on corresponding primary antibodies for 60 min (diluted 1:100 or 1:50 in PBS-BT). Grids were washed in PBS-BT for 5 min and incubated for another 60 min on a drop of either 12 nm- or 15 nm-gold-conjugated goat anti-mouse IgG or goat anti-rabbit IgG (both from British Biocell International; Braunschweig, Germany) diluted 1:100 in PBS-BT, respectively. Finally, grids were washed twice in dH2O for 5 min. After blotting off excess liquid with filter paper, negative staining, and air drying, grids were examined in a Zeiss (Oberkochen, Germany) 109 transmission electron microscope equipped with a wide-angle slow scan CCD Camera 689 (GATAN GmbH; Munich, Germany). Control experiments included negative staining of unaltered host strain DH10B and labeling of recombinant strains, whereby monoclonal and polyclonal primary antibodies were substituted with an irrelevant primary antibody.
Negative Staining and Immunolabeling of CS3 ETEC DS7-3 (Figures 1A and 1B) and DS198-1 (Figures 1C and 1D) were used as reference strains for the characterization of the CS3 surface antigen. CS3 surface antigens showed a thin and curly morphology (Figures 1A and 1C). Likewise, immunogold labeling with both monoclonal and polycolonal antibodies was highly specific and, thus, unequivocally confirmed these hair-like structures to be CS3 (Figures 1B and 1D).
In contrast to their appearance in wild-type strains, CS3 surface antigens produced variable electron-dense clusters in recombinant strain DH10B(pSSVI215-CS3/pM392) (Figure 1E) as demonstrated by negative staining. However, their presence was clearly demonstrated by immunolabeling (Figure 1F). Furthermore, labeled debris was commonly seen in between the bacteria (Figure 1F).
Negative Staining and Immunolabeling of CS6
In accordance with the observations made on wild-type strains, CS6 fimbriae also could not be demonstrated on recombinant strain DH10B(pM295) (Figure 2C). Notwithstanding, the specific labeling signal obtained with polyclonal rabbit anti-CS6 antibodies (Figure 2D) was similar to the labeling density seen in wild-type strain E34420A (Figure 2B).
Controls
Evidence for the presence of a gene, its translation into a protein, and indication of surface expression can be provided by molecular biology methods, slide agglutination, immunospots, immunofluorescence, and pili ELISA. However, the ultimate proof for proper expression in the correct location to elicit an immune response can only be granted by structural and immunologic analysis. Therefore, we used transmission electron microscopy in combination with negative staining and immunogold labeling to assess the expression of coli-specific CS3 and CS6 in recombinant E.coli-K12 strain DH10B. Expression of fimbriae was dependent on culture conditions and sample handling. Factors affecting morphological appearance of fimbriae included composition of culture medium, temperature, growing time, and centrifugation. These parameters were adjusted for maximum expression and optimal preservation of fimbriae and led to the protocol reported above.
Bacteria were grown in CF medium (Evans et al. 1979 Interestingly, small fimbriae such as CS3 and CS6 turned out to be more vulnerable in wild-type strains as compared with CFA/I pili and even more so in recombinant strains. Obviously, expression of corresponding genes produces frailer fimbriae than in donor strains. Thus, avoiding any centrifugation steps by simply rinsing off the bacteria from the agar plates with NaCl substantially improved the preservation of fimbriae. But even after the most gentle treatment, CS3 fimbriae were partly lost in recombinant strain DH10B(pSSVI215-CS3/pM392). Obviously, shear stress caused by blotting off excess liquid from the grid with filter paper is enough to detach fimbriae from the bacterial body. On the other hand, CS6 fimbriae seem to be so short that they do not protrude enough from the bacterial surface to be detectable by negative staining. However, a small fringe of PTA was retained, thus providing suggestive evidence for the presence of fimbriae. Presence of CS6 surface antigens was unequivocally demonstrated by conspicuous immunolabeling on strains E34420A and DH10B(pM295). This provided compelling evidence for the expression of immunologically identical CS6 on recombinant strains as compared with wild-type ETEC. The current study presents an effective approach allowing the expression of surface antigens to be assessed both morphologically and immunologically. This phenotypical and immunological appraisal provides a valuable tool to investigate various factors affecting the expression of genes encoding surface antigens. In addition, morphological assessment of gene expression may be a crucial step in the development of new vaccines. Some live attenuated bacterial vaccine strains have been used for decades and, thus, have been characterized comprehensively. Such strains represent promising carriers into which the genes encoding potentially immunogenic proteins might be introduced. Any resulting new vaccine, however, needs to be carefully assessed with respect to proper gene expression at the protein and structural level. The method presented in this paper thus provides a basis for the validation of potential recombinant bacterial vaccines prior to clinical trials.
This study was supported by the Federal Office for Professional Education and Technology (OPET Grant KTI 7304.1 LSPP-LS). The technical support of Cynthia Furer, Yvonne Schlatter, Corinne Hug, and Simon König is gratefully acknowledged. We are also indebted to M.K. Wolf for the generous gifts of ETEC strains DS7-3 and DS198-1 and for plasmids pM295 and pM392. ETEC strain E34420A was kindly and generously made available by W. Gaastra and the antisera against CS3 and CS6 by F. Cassels.
Received for publication July 27, 2005; accepted November 22, 2005
Burnette WN (1981) Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195203[CrossRef][Medline] de Lorimier AJ, Byrd W, Hall ER, Vaughan WM, Tang D, Roberts ZJ, McQueen CE, et al. (2003). Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6. Vaccine 21:25482555[CrossRef][Medline] Evans DG, Evans DJ Jr, Clegg S, Pauley JA (1979) Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun 25:738748 Jonson AB, Normark S, Rhen M (2005) Fimbriae, pili, flagella and bacterial virulence. Contrib Microbiol 12:6789[Medline] Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123140[CrossRef][Medline] Knutton S, Lloyd DR, Candy DC, McNeish AS (1985) Adhesion of enterotoxigenic Escherichia coli to human small intestinal enterocytes. Infect Immun 48:824831 Knutton S, McConnell MM, Rowe B, McNeish AS (1989) Adhesion and ultrastructural properties of human enterotoxigenic Escherichia coli producing colonization factor antigens III and IV. Infect Immun 57:33643371 Levine MM, Ristaino P, Marley G, Smyth C, Knutton S, Boedeker E, Black R, et al. (1984) Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun 44:409420 Nishikawa Y, Helander A, Ogasawara J, Moyer NP, Hanaoka M, Hase A, Yasukawa A (1998) Epidemiology and properties of heat-stable enterotoxin-producing Escherichia coli serotype O169:H41. Epidemiol Infect 121:3142[CrossRef][Medline] Wolf MK, de Haan LA, Cassels FJ, Willshaw GA, Warren R, Boedeker EC, Gaastra W (1997) The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits. FEMS Microbiol Lett 148:3542[CrossRef][Medline] Wolf MK, Taylor DN, Boedeker EC, Hyams KC, Maneval DR, Levine MM, Tamura K, et al. (1993) Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East. J Clin Microbiol 31:851856 Yu J, Cassels F, Scharton-Kersten T, Hammond SA, Hartman A, Angov E, Corthesy B, et al. (2002) Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun 70:10561068
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||